Porton Advanced is a cell and gene therapy CDMO that provides end-to-end process development, analytical development, GMP manufacturing, and testing services for its clients. Based in China and New Jersey, Porton Advanced has a 144,000-sq.-ft. facility for advanced therapy process development and cGMP manufacturing. The company is a CGT- and CMC-focused subsidiary of Porton Pharma Solutions — a globally recognized CDMO with strict compliance to regulatory and EHS standards.
